Lime Delivers Record Revenue and Profitability, Positive Free Cash Flow in 2024
18.2.2025 12:00:00 CET | Business Wire | Press release
Global Micromobility Leader’s Business Momentum Delivers Profitable GrowthGross Bookings of $810 Million, Net Revenue of $686 MillionAdjusted EBITDA Exceeds $140 Million, Up From $94 Million in 2023Free Cash Flow Positive for Second Consecutive Year
Lime, the world’s largest shared electric vehicle company, today announced record unaudited financial results for 2024, reflecting continued operating and financial momentum as the Company executes against its mission to build a future where transportation is shared, affordable and carbon-free.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250218624910/en/
Two young women ride Lime electric bikes through a city. (Photo: Business Wire)
Full Year 2024 Financial Highlights (unaudited)
- Gross bookings of $810 million, reflecting growth of 31% versus 2023
- Net revenue of $686 million, an increase of 32% compared to 2023
- Fourth consecutive year of 30%+ topline growth
- Adjusted EBITDA1 over $140 million, up from $94 million in 2023, representing year-over-year growth of 49%
- Adjusted EBITDA margin1 over 20%, representing more than 200 basis points of expansion versus prior year
- Free cash flow positive for second consecutive year
“2024 was an exceptional year for Lime and our global leadership is evident both operationally and financially with strong results across all of our key metrics,“ said Wayne Ting, CEO. “We grew profits faster than revenue in 2024, posting another record year of results through serving more than 24 million riders in hundreds of communities around the world and bringing Lime to more cities globally. As we continue to expand our fleet, our permit win and retention rates demonstrate that Lime remains the clear choice for cities seeking to reduce traffic congestion and meet carbon emission goals. While we saw record demand in 2024, we’re just scratching the surface of micromobility’s potential to transform cities and better connect people. Our proven execution, combined with these global tailwinds, position Lime for durable growth for years to come.”
Full Year 2024 Operating Highlights and Metrics
- Provided more than 200 million rides in 2024, up 30% from 2023, equating to more than six rides per second, with more than 24 million riders taking a trip in 2024
- Surpassed 750 million lifetime rides
- Won over 90% of competitive permits to operate in top tier cities
- Expanded to more than 20 new cities globally, including launches into two new countries, Japan and Greece
- Expanded average operational fleet by nearly 20% to over 270,000 vehicles globally
Lime also deepened its management team in 2024, with key executive appointments who draw on decades of experience at Fortune 500 companies. Chief Legal Officer Susie Giordano brings more than 30 years of experience in capital markets, governance, compliance and M&A, including serving as the Corporate Secretary for Intel Corporation. Incoming Chief Technology Officer Jon Jenkins joined Lime from Amazon, with prior roles including Head of Engineering at Pinterest.
“As we continue to advance our mission, we are driving consistent growth through fleet expansion, increased rider utilization, geographic expansion and continuous innovation,” said Ann Gugino, CFO. “We are well above a ‘rule of 40’ company and are intently focused on scaling our unit economics. In 2024, we invested for growth, while simultaneously delivering increased profitability and positive free cash flow. Importantly, our team has a proven track record of strong execution and Lime has an exciting roadmap and multiple avenues for growth in 2025 and beyond.”
Environmental sustainability remains a key focus for Lime and it continues to make an impact on reducing carbon emissions in cities. Last year, riders avoided an estimated 20,000 metric tons of CO2 emissions, spared an estimated 2.2 million gallons of gas (8.5M liters) from being consumed and replaced more than an estimated 43 million car trips with two-wheeled, emissions-free rides. Lime also continues to make meaningful strides in reducing its own carbon intensity across Scopes 1, 2 and 3 emissions. Its most recent carbon inventory measuring 2023 impact showed a 59.5% reduction from its 2019 baseline. Lime plans to release its 2024 carbon inventory later this spring.
About Lime
Lime’s mission is to build a future where transportation is shared, electric and carbon-free. As a leading global provider of shared electric vehicles, Lime partners with cities to deploy electric bikes and scooters to serve any trip under five miles. A Time Magazine 100 Most Influential Companies and Fast Company Brand that Matters, Lime has powered more than 750 million rides across five continents, spurring a new generation of clean alternatives to car ownership. Learn more at li.me.
_____________________
1 The company’s unaudited financial results communicated herein reflect certain non-GAAP financial measures. In particular, the Company presents adjusted EBITDA which is defined as earnings before interest, income taxes, depreciation and amortization, and excludes certain items that affect comparability from period to period or are not indicative of our ongoing operating performance, and Adjusted EBITDA margin, which is calculated as Adjusted EBITDA/Net Revenue. The non-GAAP financial measures provided in this press release are not a substitute for the company’s financial results prepared in accordance with U.S. GAAP and may be different from similarly-titled non-GAAP measures used by other companies. Unaudited financial results communicated herein are subject to change upon finalization of the audit.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250218624910/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release
Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release
Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
Half-Year Report on SES’s Liquidity Contract31.7.2026 07:30:00 CEST | Press release
Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom